Prevalence of anterior pituitary dysfunction in patients following traumatic brain injury in a German multi-centre screening program

Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):139-44. doi: 10.1055/s-0029-1225611. Epub 2009 Aug 18.

Abstract

Introduction: We determined the prevalence of anterior pituitary dysfunction in a multi-centre screening program across five German endocrine centres in patients rehabilitating from TBI (GCS<13).

Patients & methods: 246 patients (39+/-14 yrs; 133 males, 12+/-8 months after TBI) underwent a series of baseline endocrine tests with central assessment of TSH, free T4, prolactin, LH, FSH, testosterone (m), estradiol (f), cortisol, GH, and IGF-I. If IGF-I was <-2 SDS dynamic testing was performed. GHD was defined according to BMI-dependent cut-off values for GH response to GHRH+arginine of <4.2, <8.0 and <11.5 ng/ml in obese, overweight and lean subjects, respectively, or <3 micro g/l in ITT. Hypocortisolism was suggested when basal cortisol was <200 nmol/l and confirmed by ITT (peak<500 nmol/l).

Results: In TBI patients some degree of impaired pituitary function was shown in 21% (n=52/246). Total, multiple and isolated deficits were present in 1%, 2% and 18%, respectively. 19% had an IGF-I of <-1 SDS, 9% of <-2 SDS. In 5% GHD was confirmed. 9% had hypogonadism. 4% had hypocortisolism and 1% of patients had confirmed ACTH-deficiency. 12% had TSH-deficiency.

Summary: In summary, in this large series carried out on an unselected group of TBI survivors we have found hypopituitarism in every fifth patient with predominantly secondary hypogonadism and hypothyreosis. Regarding somatotrope insufficiency IGF-I is decreased in 50% of GHD patients.

Conclusion: These findings strongly suggest that patients who suffer head trauma should routinely undergo endocrine evaluation.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Injuries / blood
  • Brain Injuries / complications*
  • Brain Injuries / rehabilitation
  • Estradiol / blood
  • Female
  • Germany
  • Humans
  • Hydrocortisone / blood
  • Insulin-Like Growth Factor I / metabolism
  • Luminescent Measurements
  • Male
  • Middle Aged
  • Pituitary Diseases / blood
  • Pituitary Diseases / complications
  • Pituitary Diseases / epidemiology*
  • Pituitary Hormones, Anterior / blood*
  • Prevalence
  • Testosterone / blood

Substances

  • Pituitary Hormones, Anterior
  • Testosterone
  • Estradiol
  • Insulin-Like Growth Factor I
  • Hydrocortisone